XTL Biopharmaceuticals Ltd. Made Headway
Tue, Jan 13, 2026 at 07:22 PM
XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ) shot up at $1.07, a gain of 56.7%. On Tue, Jan 13, 2026, XTLB:NASDAQ hit a New 2-Week High of $1.07. The stock got featured on our News Catalysts scanner on Tue, Jan 13, 2026 at 04:19 PM in the 'MISCELLANEOUS' category. From Tue, Dec 30, 2025, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Tue, Jan 13, 2026 at $1.41 with a volume of 36M+.
About XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ)
XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 276.19%
- Beyond Air, Inc. (XAIR:NASDAQ), 150%
- TryHard Holdings Limited (THH:NASDAQ), 138.31%
- Ambitions Enterprise Management Co. L.L.C (AHMA:NASDAQ), 133.71%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 56.66%
- HUB Cyber Security Ltd. (HUBC:NASDAQ), 56.49%
- JIADE Limited (JDZG:NASDAQ), 53.63%
- iOThree Limited (IOTR:NASDAQ), 52.11%
- Decoy Therapeutics Inc Com Par $0.0001 (New) (DCOY:NASDAQ), 50.64%
- BriaCell Therapeutics Corp. (BCTX:NASDAQ), 43.12%